Novel Drug Delivery Systems (NDDS) Market Report

China Novel Drug Delivery Systems (NDDS) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 02, 2023
  • PAGES：234
  • REPORT CODE：GMM1820611
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Novel Drug Delivery Systems (NDDS): refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body to safely achieve its desired therapeutic effects. Novel drug delivery systems (NDDS) are innovative approaches that aim to enhance the efficacy, safety, and convenience of drug delivery.

    The positive impact of COVID-19 on the industry The emergence of the COVID-19 pandemic has had a very significant impact on the market for novel drug delivery systems, as it has accelerated research into the development of effective treatments for COVID-19, such as vaccines, as well as marketable inputs. Novel coronavirus is an mRNA virus, and the difficulty of vaccine against virus lies in delivery, which refers to the carrier that protects the effective transportation of mRNA vaccine to the target and timely release. The commonly used vectors for mRNA vaccine delivery include Lipid nanoparticles (LNP), composites and polymer nanoparticles, dendritic cells (DC), peptides, and squalene-based cationic nanoemulsions. Among them, lipid nanoparticles (LNP) are currently the most widely used mRNA delivery technology in clinical practice, playing a pivotal role in effectively protecting mRNA and transporting it to the cytoplasm. Most of the COVID-19 vaccines used LNP as the vaccine carrier. And during the pandemic, governments have invested heavily in vaccine research and development in order to accelerate the process of vaccine research, such as, for example, in January 2020, Astrazeneca received more than $1.9 billion in funding from the US Department of Health's Biomedical Advanced Research and Development Agency (BARDA). For the development, production and delivery of the COVID-19 2021 vaccine at Oxford University. In addition, many studies have mentioned different novel drug delivery systems and the positive results of these studies could have a positive impact on the research market. In order to protect more people from the pandemic, many governments have lowered their regulatory policies so that new vaccines can be brought to market faster. So for the industry, the coronavirus pandemic is a positive.

    Pfizer, Inc. is one of the major players operating in the Novel Drug Delivery Systems (NDDS) market, holding a share of 20.19% in 2023. Pfizer is a multinational pharmaceutical and biotechnology company with American origins and is one of the world's largest pharmaceutical companies, with a portfolio that includes pharmaceuticals and vaccines, as well as many of the world's best-known consumer healthcare products. Moderna is a multinational pharmaceutical and biotechnology company headquartered in Cambridge, Massachusetts, United States, focused on cancer immunotherapy, including mRNA-based drug discovery, drug discovery, and vaccine technology.

    Among different product types,PEGylated Proteins & Polypeptides segment is anticipated to contribute the largest market share in 2028. Liposomal and Lipid Nanoparticle Liposomes are composed of cholesterol and natural non-toxic phospholipids, while lipid nanoparticles are nanoparticles composed of lipids. Both are advanced drug delivery systems designed to protect loaded drug molecules from external degradation. PEGylated Proteins & Polypeptides As a widely used polymer carrier in PEC, polyethylene glycol is more reflected in changing the physical and chemical properties of the compound so that the prodrug can be activated after reaching the specific target of action, or changing the fat solubility or water solubility of small molecules to reduce the toxic side effects. It can be classified into passive targeted drug delivery systems and targeted drug delivery systems. Microspheres Microsphere preparations refer to small spheres or spheroids formed by dissolving or dispersing drugs in natural or synthetic polymer materials, the particle size is generally in the range of 1-250μm. The drug is embedded or adsorbed on the surface of the polymer molecule by the microsphere, and then injected into the body by subcutaneous or intramuscular injection. The slow release of the drug can be realized by means of rapid release on the carrier surface, drug diffusion, polymer dissolution and degradation, etc., which can prolong the half-life of the drug. Drug Conjugates Conjugated drug is a kind of compound that combines cytotoxic molecules with tumor-targeting components to make cytotoxic molecules targeted therapeutic drugs.

    By application, the Hospitals & Clinic segment occupied the biggest share from 2018 to 2022. Hospitals & Clinic A hospital is a health-care facility that provides specialized medical and nursing care as well as medical supplies to patients. The most well-known form of the hospital is the general hospital, which usually carries an emergency department to handle urgent health issues. Based on the source of revenue, hospitals are categorized as general, specialized, or government. Drugs containing Liposomal and Lipid Nanoparticle are usually sold or used in hospitals. Retail Pharmacy The definition of a retail pharmacy is a pharmacy acting as a retail store, selling drugs to patients. Retail pharmacists are responsible for dispensing medications correctly for customers to use at home, as well as educating the customers on their medications and answering questions the customers have. Drugs containing liposomal and lipid nanoparticle are also sold in retail pharmacy.

    The development of pharmacy and the pursuit of curative effect With the rapid development of disease therapies, drug delivery technologies are also rapidly evolving to adapt to changing drug delivery needs. Decades ago, small molecule drugs were the mainstay of disease treatment, and new delivery challenges have emerged with the emergence of next-generation therapeutics such as peptides, proteins, monoclonal antibodies (mAbs), nucleic acids, and living cells , such as the stability of peptides and proteins, the efficiency of intracellular delivery of nucleic acids, the feasibility and scalability of live cell therapy, etc. Moreover, with the discovery of more insoluble drugs, the emergence of living drug forms such as cell therapy and gene therapy drugs, more and more drugs are difficult to exert their curative effect through traditional preparation methods. At this time, more cutting-edge preparation technologies are needed for drug delivery. According to the World Health Organization report on cancer, cancer is the leading cause of death worldwide and will kill nearly 10 million people in 2020, or nearly one in six deaths. Among them, targeted drugs have significant curative effects on a variety of malignant tumors due to their high specificity and low toxicity and side effects, and have become the mainstream of new anti-tumor drugs in the past ten years. According to studies and reports, there has been a substantial increase in cancer drug pipelines and related investments. The growth of downstream demand promotes the development of this industry.

    This report elaborates on the current development of the Novel Drug Delivery Systems (NDDS) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Takeda Pharmaceutical

    • Bayer HealthCare Pharmaceuticals

    • F Hoffmann-La Roche AG

    • Pacira BioSciences

    • Luye Pharma Group

    • Pfizer, Inc

    • BMS

    • Moderna

    • Novartis International AG

    • Kinyond

    • Leadiant Biosciences

    • Amgen

    • Sun Pharmaceutical

    • Alnylam

    • Ipsen

    • CSPC

    • Johnson & Johnson

    By Type:

    • PEGylated Proteins & Polypeptides

    • Liposomal and Lipid Nanoparticle

    • Others

    • Microspheres 

    • Drug Conjugates

    By Application:

    • Retail Pharmacy

    • Hospitals & Clinic

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Novel Drug Delivery Systems (NDDS) Market Overview 2018-2029

    • 1.1 China Novel Drug Delivery Systems (NDDS) Industry Development Overview

    • 1.2 China Novel Drug Delivery Systems (NDDS) Industry Development History

    • 1.3 China Novel Drug Delivery Systems (NDDS) Industry Market Size (2018-2029)

    • 1.4 China Novel Drug Delivery Systems (NDDS) Market Analysis by Type from Production Side

      • 1.4.1 China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of PEGylated Proteins & Polypeptides (2018-2029)

      • 1.4.2 China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Liposomal and Lipid Nanoparticle (2018-2029)

      • 1.4.3 China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Microspheres  (2018-2029)

      • 1.4.5 China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Drug Conjugates (2018-2029)

    • 1.5 China Novel Drug Delivery Systems (NDDS) Market Analysis by Application from Consumption End

      • 1.5.1 China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

      • 1.5.2 China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Hospitals & Clinic (2018-2029)

      • 1.5.3 China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Novel Drug Delivery Systems (NDDS) Market Analysis by Region

      • 1.6.1 North China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Novel Drug Delivery Systems (NDDS) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Novel Drug Delivery Systems (NDDS) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Novel Drug Delivery Systems (NDDS) Market Status and Competition Analysis in 2023

      • 2.2.3 China Novel Drug Delivery Systems (NDDS) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Novel Drug Delivery Systems (NDDS) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Novel Drug Delivery Systems (NDDS) Industry Development

    Chapter 3 Novel Drug Delivery Systems (NDDS)Industry Chain Analysis

    • 3.1 Novel Drug Delivery Systems (NDDS) Industry Chain

    • 3.2 Novel Drug Delivery Systems (NDDS) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Novel Drug Delivery Systems (NDDS) Market

    • 3.3 Novel Drug Delivery Systems (NDDS) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Novel Drug Delivery Systems (NDDS) Market

    Chapter 4 China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 4.1 China Novel Drug Delivery Systems (NDDS) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Novel Drug Delivery Systems (NDDS) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate, by Type

      • 4.5.1 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of PEGylated Proteins & Polypeptides

      • 4.5.2 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Liposomal and Lipid Nanoparticle

      • 4.5.3 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Others

      • 4.5.4 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Microspheres 

      • 4.5.5 China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Drug Conjugates

    Chapter 5 China Novel Drug Delivery Systems (NDDS) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Novel Drug Delivery Systems (NDDS) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate, by Application

      • 5.5.1 China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Retail Pharmacy

      • 5.5.2 China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Hospitals & Clinic

      • 5.5.3 China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Others

    Chapter 6 China Novel Drug Delivery Systems (NDDS) Market, by Region

    • 6.1 China Novel Drug Delivery Systems (NDDS) Production Volume and Production Value, by Region

    • 6.2 China Novel Drug Delivery Systems (NDDS) Sales Volume and Sales Value, by Region

    Chapter 7 North China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 7.1 North China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 7.2 North China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 8 Central China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 8.1 Central China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 8.2 Central China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 9 South China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 9.1 South China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 9.2 South China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 10 East China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 10.1 East China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 10.2 East China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 11 Northeast China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 11.1 Northeast China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 11.2 Northeast China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 12 Southwest China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 12.1 Southwest China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 12.2 Southwest China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 13 Northwest China Novel Drug Delivery Systems (NDDS) Market Analysis

    • 13.1 Northwest China Novel Drug Delivery Systems (NDDS) Market, by Type

    • 13.2 Northwest China Novel Drug Delivery Systems (NDDS) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Takeda Pharmaceutical

        • 14.1.1 Takeda Pharmaceutical Company Profile

        • 14.1.2 Takeda Pharmaceutical Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bayer HealthCare Pharmaceuticals

        • 14.2.1 Bayer HealthCare Pharmaceuticals Company Profile

        • 14.2.2 Bayer HealthCare Pharmaceuticals Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 F Hoffmann-La Roche AG

        • 14.3.1 F Hoffmann-La Roche AG Company Profile

        • 14.3.2 F Hoffmann-La Roche AG Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pacira BioSciences

        • 14.4.1 Pacira BioSciences Company Profile

        • 14.4.2 Pacira BioSciences Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Luye Pharma Group

        • 14.5.1 Luye Pharma Group Company Profile

        • 14.5.2 Luye Pharma Group Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer, Inc

        • 14.6.1 Pfizer, Inc Company Profile

        • 14.6.2 Pfizer, Inc Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BMS

        • 14.7.1 BMS Company Profile

        • 14.7.2 BMS Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Moderna

        • 14.8.1 Moderna Company Profile

        • 14.8.2 Moderna Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis International AG

        • 14.9.1 Novartis International AG Company Profile

        • 14.9.2 Novartis International AG Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Kinyond

        • 14.10.1 Kinyond Company Profile

        • 14.10.2 Kinyond Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Leadiant Biosciences

        • 14.11.1 Leadiant Biosciences Company Profile

        • 14.11.2 Leadiant Biosciences Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Amgen

        • 14.12.1 Amgen Company Profile

        • 14.12.2 Amgen Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Sun Pharmaceutical

        • 14.13.1 Sun Pharmaceutical Company Profile

        • 14.13.2 Sun Pharmaceutical Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Alnylam

        • 14.14.1 Alnylam Company Profile

        • 14.14.2 Alnylam Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Ipsen

        • 14.15.1 Ipsen Company Profile

        • 14.15.2 Ipsen Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 CSPC

        • 14.16.1 CSPC Company Profile

        • 14.16.2 CSPC Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Johnson & Johnson

        • 14.17.1 Johnson & Johnson Company Profile

        • 14.17.2 Johnson & Johnson Novel Drug Delivery Systems (NDDS) Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Novel Drug Delivery Systems (NDDS) Industry Research Conclusions

    • 15.2 Novel Drug Delivery Systems (NDDS) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Novel Drug Delivery Systems (NDDS) Industry Market Size (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of PEGylated Proteins & Polypeptides (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Liposomal and Lipid Nanoparticle (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Microspheres  (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume, Production Value and Growth Rate of Drug Conjugates (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Hospitals & Clinic (2018-2029)

    • Figure China Novel Drug Delivery Systems (NDDS) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure Central China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure South China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure East China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate from 2018-2029

    • Figure Novel Drug Delivery Systems (NDDS) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Novel Drug Delivery Systems (NDDS) Market Share by Type in 2018

    • Figure China Novel Drug Delivery Systems (NDDS) Market Share by Type in 2023

    • Figure China Novel Drug Delivery Systems (NDDS) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of PEGylated Proteins & Polypeptides (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Liposomal and Lipid Nanoparticle (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Microspheres  (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume and Growth Rate of Drug Conjugates (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Market Share by Application in 2018

    • Figure China Novel Drug Delivery Systems (NDDS) Market Share by Application in 2023

    • Figure China Novel Drug Delivery Systems (NDDS) Total Market Size and Growth Rate from Consumption End

    • Figure China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Retail Pharmacy (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Hospitals & Clinic (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Market Size and Growth Rate of Others (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Production Volume by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Production Volume Share by Region (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Volume Share by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Production Value by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Production Value Share by Region (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Production Value Share by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Sales Volume by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Region (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Sales Value by Region (2018-2023)

    • Table China Novel Drug Delivery Systems (NDDS) Sales Value Share by Region (2018-2023)

    • Figure China Novel Drug Delivery Systems (NDDS) Sales Value Share by Region (2018-2023)

    • Table North China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table North China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure North China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table North China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table North China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure North China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table Central China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table Central China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure Central China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table Central China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table Central China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure Central China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table South China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table South China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure South China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table South China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table South China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure South China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table East China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table East China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure East China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table East China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table East China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure East China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table Northeast China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table Northeast China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table Northeast China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table Southwest China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table Southwest China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table Southwest China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Novel Drug Delivery Systems (NDDS) Production Volume by Type (2018-2023)

    • Table Northwest China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Novel Drug Delivery Systems (NDDS) Production Volume Share by Type (2018-2023)

    • Table Northwest China Novel Drug Delivery Systems (NDDS) Sales Volume by Application (2018-2023)

    • Table Northwest China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Novel Drug Delivery Systems (NDDS) Sales Volume Share by Application (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Pharmaceuticals Company Profile

    • Table Bayer HealthCare Pharmaceuticals Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Pacira BioSciences Company Profile

    • Table Pacira BioSciences Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Luye Pharma Group Company Profile

    • Table Luye Pharma Group Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table BMS Company Profile

    • Table BMS Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Moderna Company Profile

    • Table Moderna Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Kinyond Company Profile

    • Table Kinyond Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Leadiant Biosciences Company Profile

    • Table Leadiant Biosciences Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Company Profile

    • Table Sun Pharmaceutical Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Alnylam Company Profile

    • Table Alnylam Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Ipsen Company Profile

    • Table Ipsen Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table CSPC Company Profile

    • Table CSPC Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Novel Drug Delivery Systems (NDDS) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US